The Treatment of Opsoclonus-Myoclonus Syndrome Secondary to Neuroblastic Tumours—Single-Centre Experience and Literature Review

Background and Objectives: The opsoclonus-myoclonus syndrome (OMS) is characterised by opsoclons, myoclons and impaired balance, often concomitant with sleep disorder and behavioural difficulties. The symptoms develop as a result of autoimmune response triggered by a neuroblastic tumour (NT). OMS ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Mizia-Malarz, Agnieszka, Stolpa, Weronika, Sobol-Milejska, Grażyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466285/
https://www.ncbi.nlm.nih.gov/pubmed/32823831
http://dx.doi.org/10.3390/medicina56080412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466285/
https://www.ncbi.nlm.nih.gov/pubmed/32823831
http://dx.doi.org/10.3390/medicina56080412

Ejemplares similares